Pavan Cheruvu
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Pavan K.
Cheruvu is currently Chief Executive Officer & Director at Amanat Acquisition Corp.
Former positions include Chief Executive Officer at Sio Gene Therapies, Inc. from 2018 to 2018, Chief Executive Officer at Axovant Sciences, Inc. from 2018 to 2020, and President, Chief Executive Officer & Director at Bitterroot Bio, Inc. Education includes undergraduate studies at Duke University, graduate studies at the University of Oxford, and a doctorate from Harvard Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
6,9 % | 20/05/2026 | 150.000 ( 6,9 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Director Ejecutivo | 01/02/2026 |
| SIO GENE THERAPIES INC. | Director Ejecutivo | 31/01/2022 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director Ejecutivo | 01/12/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.